Have You Heard What Healthcare Providers Are Saying About
Adding Once-a-Day Oxtellar XR®
for Their Patients Who Are Still Having Partial Seizures?

Learn More

If You Are Still Having Partial Seizures, or if Someone You Love Is Experiencing Them,
Adding Once-a-Day Oxtellar XR®
May Be a Good Option

Talk to Your Healthcare Provider Today

Learn More

Eligible Patients May Qualify for a $0 Co-pay* for
Once-a-Day Oxtellar XR®

Ask Your Healthcare Provider if Adding It Is a Good Fit for You!

Learn More


  1. Data on file. Supernus Pharmaceuticals, Inc. Rockville MD.
  2. French JA, Baroldi P, Brittain ST, Johnson JK; on behalf of the PROSPER Investigators Study Group. Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial. Acta Neurol Scand. 2014;129:143-153.
  3. Oxtellar XR [package insert]. Rockville, MD: Supernus Pharmaceuticals, Inc.; December 2015.